as on January 1, 1901 at 12:00 am IST
as on January 1, 2001 at 5:53 am IST
Market Cap
₹1,042.09 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
14.82
Return on capital employed (ROCE)
11.75
Beta (LTM)
1.14
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.41
Quarterly Earnings Growth YOY
0EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
0Compare market cap, revenue, PE, and other key metrics of Rekvina Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,042.09 | 69.43% | 0.50 | 45 | 647 | |
| BUY | 14,053.04 | 53.29% | 0.51 | 541 | 1,937 | |
| NA | 104.99 | 198.21% | 0.00 | -3 | 8 | |
| NA | 67.32 | -11.43% | 0.71 | 10 | 120 | |
| NA | 870.21 | -4.93% | 0.61 | 21 | 368 |
Get share price movements and forecasts by analysts on Rekvina Labs.
Source: S&P Global Market Intelligence
| Organisation | Rekvina Labs Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
To buy Rekvina Labs shares, you need to follow these steps:
Rekvina Labs trading volume is 0.00 as on . This means that 0.00 shares of Rekvina Labs were bought and sold on the stock market during today's trading session.